3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione

C49H56F3N11O4 — CID 176936274

IUPAC3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione
SMILESCc1cnc(N2C=CC3(CCN(CC4CCN(c5cc6c(cc5F)c(C5CCC(=O)NC5=O)nn6C)CC4)CC3)CC2)nc1Nc1ccc2c(c1)c1c(c(=O)n2C)OCC(F)(F)[C@H](C2CC2)N1
InChIInChI=1S/C49H56F3N11O4/c1-28-25-53-47(57-44(28)54-31-6-8-36-33(22-31)41-42(46(66)59(36)2)67-27-49(51,52)43(56-41)30-4-5-30)63-20-14-48(15-21-63)12-18-61(19-13-48)26-29-10-16-62(17-11-29)38-24-37-34(23-35(38)50)40(58-60(37)3)32-7-9-39(64)55-45(32)65/h6,8,14,20,22-25,29-30,32,43,56H,4-5,7,9-13,15-19,21,26-27H2,1-3H3,(H,53,54,57)(H,55,64,65)/t32?,43-/m0/s1
InChIKeyUJWSUBCCTVFNGD-INYKVJDPSA-N
MW920.05 g/mol
LogP6.87
Rot. Bonds8

About 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione

3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione (PubChem CID 176936274) has the molecular formula C49H56F3N11O4 and a molecular weight of 920.05 g/mol. Its IUPAC name is 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione.

Molecular Properties

Compound Name3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione
PubChem CID176936274
Molecular FormulaC49H56F3N11O4
Molecular Weight920.05 g/mol
Exact Mass919.45
IUPAC Name3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione
SMILESCc1cnc(N2C=CC3(CCN(CC4CCN(c5cc6c(cc5F)c(C5CCC(=O)NC5=O)nn6C)CC4)CC3)CC2)nc1Nc1ccc2c(c1)c1c(c(=O)n2C)OCC(F)(F)[C@H](C2CC2)N1
InChIInChI=1S/C49H56F3N11O4/c1-28-25-53-47(57-44(28)54-31-6-8-36-33(22-31)41-42(46(66)59(36)2)67-27-49(51,52)43(56-41)30-4-5-30)63-20-14-48(15-21-63)12-18-61(19-13-48)26-29-10-16-62(17-11-29)38-24-37-34(23-35(38)50)40(58-60(37)3)32-7-9-39(64)55-45(32)65/h6,8,14,20,22-25,29-30,32,43,56H,4-5,7,9-13,15-19,21,26-27H2,1-3H3,(H,53,54,57)(H,55,64,65)/t32?,43-/m0/s1
InChIKeyUJWSUBCCTVFNGD-INYKVJDPSA-N
XLogP6.87
TPSA154.78 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms67
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500920.05
LogP ≤ 56.87
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione?
The IUPAC name of 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione (CID 176936274) is 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione.
What is the SMILES notation for 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione?
The canonical SMILES for 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione is Cc1cnc(N2C=CC3(CCN(CC4CCN(c5cc6c(cc5F)c(C5CCC(=O)NC5=O)nn6C)CC4)CC3)CC2)nc1Nc1ccc2c(c1)c1c(c(=O)n2C)OCC(F)(F)[C@H](C2CC2)N1.
What is the InChIKey of 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione?
The InChIKey is UJWSUBCCTVFNGD-INYKVJDPSA-N. The full InChI is InChI=1S/C49H56F3N11O4/c1-28-25-53-47(57-44(28)54-31-6-8-36-33(22-31)41-42(46(66)59(36)2)67-27-49(51,52)43(56-41)30-4-5-30)63-20-14-48(15-21-63)12-18-61(19-13-48)26-29-10-16-62(17-11-29)38-24-37-34(23-35(38)50)40(58-60(37)3)32-7-9-39(64)55-45(32)65/h6,8,14,20,22-25,29-30,32,43,56H,4-5,7,9-13,15-19,21,26-27H2,1-3H3,(H,53,54,57)(H,55,64,65)/t32?,43-/m0/s1.
What are the key properties of 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione?
3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione has a molecular weight of 920.05 g/mol, XLogP of 6.87, 8 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[6-[4-[[3-[4-[[(2S)-2-cyclopropyl-3,3-difluoro-7-methyl-6-oxo-2,4-dihydro-1H-[1,4]oxazepino[2,3-c]quinolin-10-yl]amino]-5-methylpyrimidin-2-yl]-3,9-diazaspiro[5.5]undec-4-en-9-yl]methyl]piperidin-1-yl]-5-fluoro-1-methylindazol-3-yl]piperidine-2,6-dione is sourced from PubChem (CID 176936274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).